Glucotrack, Inc. (GCTK): Nasdaq/NYSE listing notice — GlucoTrack receives Nasdaq delisting notice for missing annual meeting; plans to hold by March 31

Glucotrack, Inc.

Nasdaq notified GlucoTrack on Jan 4, 2023 of non-compliance for failing to hold annual meeting within 12 months of FYE Dec 31, 2021.
Company has 45 calendar days to submit a compliance plan; a plan to hold meeting by March 31, 2023 has already been submitted.
If Nasdaq accepts the plan, it may grant an exception until June 29, 2023 to regain compliance.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Glucotrack, Inc. received a nasdaq noncompliance notice notice regarding shareholders.

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: shareholders

Exact text from the filing

January 4, 2023, GlucoTrack, Inc. (the “Company”) received a notification from Nasdaq that since it had not held an annual meeting of shareholders within twelve months of the end of the Company’s fiscal year end ended December 31, 2021, it no longer complies with our Listing Rules (the “Rules”) for continued listing. Under our Rules the Company has 45 calendar days to submit a plan to regain compliance and if plan is accepted, Nasdaq can grant an exception of up to 180 calendar days from the fiscal year end, or until June 29, 2023, to regain compliance. The Company has already submitted a plan

View on SEC.gov

Browse all listing & compliance notices →

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-001085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.